# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Jefferies analyst Glen Santangelo maintains Teladoc Health (NYSE:TDOC) with a Hold and raises the price target from $8 to $10.
JP Morgan analyst Lisa Gill maintains Teladoc Health (NYSE:TDOC) with a Neutral and lowers the price target from $16 to $9.
ARKK's high-risk, high-reward strategy has led to a rollercoaster ride with no brakes, while QQQ's safer bet on establi...
Cantor Fitzgerald analyst Sarah James reiterates Teladoc Health (NYSE:TDOC) with a Overweight and maintains $10 price target.